Metabolism.com
  • Home
  • About us
  • The Thyroid Project
  • Health & Nutrition
  • Contact Us
Select Page

New Diabetes Medications Cost 100 Times More than Established Treatments

by Gary Pepper M.D. | Oct 6, 2014 | diabetes, Family Nutrition Diabetes, general health & nutrition, health insurance, Medical Economics

by Gary Pepper, M.D. “New is not always better.” This caution seems reasonable when considering the value of the recently approved medications for treatment of Type 2 (adult type) diabetes.  These drugs include three new classes of medication referred to...

Are New Diabetes Medications Worth the Money?

by Dr. G. Pepper | May 16, 2011 | diabetes, diet, general health & nutrition, health, metabolism, weight gain

(I don’t think so, and here’s why.) The FDA just announced its approval of linagliptin (Tradjenta), a new diabetes medication developed by Eli Lilly and Company and Boehringer Inglheim. Linagliptin is the third drug to be approved in the class of medications...

Categories

Polls

  • Polls Archive

After graduating from fellowship in Endocrinology
and Metabolism at Mt. Sinai School of Medicine in
New York, in 1981.

COMPANY

  • Home
  • About Us
  • The Thyroid Project
  • Health & Nutrition
  • Contact Us

RESOURCES

  • Blog
  • Terms & Condidtions
  • Privcay Policy
  • Disclaimer

CONTACT US

  • info@metabolism.com
  • P.O. Box 2743, Jupiter,
    Florida 33468

Copyright © 2023 Metabolism.com